LONDON – AMSTERDAM
LONDON – AMSTERDAM

H2 Equity Partners facilitates the creation of one of the leading Healthcare, Scientific, Sales & Distribution companies in Ireland, the UK and abroad

H2 Equity Partners is pleased to announce its fifth investment by Fund V: parallel investments in Healthcare 21 and Aquilant with the aim to create a new market-leading group in healthcare and scientific sales & distribution – partnering with the shareholders of Healthcare 21.

H2 Equity Partners recently completed the acquisition of Aquilant and has reached agreement to invest in Healthcare 21 Group with the aim to facilitate the creation of a new market-leading group consisting of Aquilant and Healthcare 21. The envisaged transaction is subject only to Competition Authority approval – and is expected to complete by the end of September 2018.

The combined companies will have a turnover in excess of €150 million and employ 450 people across Ireland, the UK, Germany and Austria. The businesses complement each other extremely well and the combined group offers an expanded product portfolio in many exciting therapy areas. In addition, the combined group’s infrastructure and expertise will ensure that both companies can maintain focus on their current plans and continue to deliver world class outcomes for their customers and suppliers alike.

Healthcare 21, Aquilant and H2 Equity Partners expect to accelerate the growth of the combined group as we drive to become Europe’s largest and best-in-class provider of outsourced sales, marketing and service solutions for the new group’s suppliers and customers.

For further information on Healthcare21 and Aquilant please refer to:
www.healthcare21.eu
www.aquilant.net

©2024 H2 Equity Partners – Disclaimer & Legal notice here | Privacy notice here

Henry Stevens

Senior Associate

 

Henry joined H2 in 2024 and is involved in both evaluating new investment opportunities and supporting existing portfolio companies.

 

Prior to joining H2, Henry spent nearly six years at the strategy consultancy firm, Roland Berger, where he was a core member of the Transaction & Investor Services platform supporting private equity and strategic investors across the Industrial and Regulated & Infrastructure sectors predominantly within the mid-market.

 

Henry graduated from the University of Cambridge with a Bachelor (Hons) in Economics. His interests outside of work are road cycling where he competes in time trials, running and skiing.

Terry Musson

The Amberon Group is a market leading traffic management provider to the utilities and Local Authority markets. Amberon was established in May 2002 with our first depot in Paignton, South West England. Our founding core principles remain at the heart of everything that we do and our continued desire to achieve our purpose; to provide the best service in the Traffic Management sector. This has been the foundation for our success and has cemented our position as the market leader in TM.

During the initial transaction we never felt under any pressure & instantly recognised we would become part of the family. H2 took the time to listen to our views & business strategy, it was obvious from the very beginning that they would be the perfect partner for us.

The guys at H2 have enabled us to continue the momentum & have provided the expertise & knowledge to help us continue on the journey to constantly improve our service offering.

Working with H2 during the last 2 years has given us additional support not just financially but the advice & expertise has helped analytically & strategically.

The ambition and the drive H2 have is extremely infectious & continues to assist the group to overachieve.

It’s enormously reassuring to know H2 will always be at the end of the phone to offer advice but heartening to know they have the trust in us to deliver.